Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9578 posts found.

karl_ludwig_kley

Merck chief executive Karl-Ludwig Kley to step down in April

March 9, 2016 Medical Communications, Research and Development Denreon, Karl-Ludwig Kley, Merck, karl ludwig kley

 It has been announced that Karl-Ludwig Kley, chief executive officer at Merck, will step down from his position at the …
Appointment
biotrial_facility_rennes

French clinical trial tragedy “astonishing and unprecedented”, says report

March 9, 2016 Medical Communications, Research and Development Bial, Biotrial, France, clinical trial, death, rennes, tragedy

A report into the clinical trial tragedy in France in January has called the event “astonishing and unprecedented” but did …
News
peptimimesis

Ipsen and PeptiMimesis announce oncology research partnership

March 9, 2016 Research and Development INSERM, PeptiMimesis, ipsen, peptides

Specialist pharma company Ipsen is partnering with French start-up PeptiMimesis to develop and market of novel therapeutic peptides in oncology. …
News
clinical_trial

Crown Bioscience expands portfolio with PreClinOmics acquisition

March 9, 2016 Manufacturing and Production, Research and Development cardiovascular, collaboration, crown bioscience, metabolic, preclinomics

Crown Bioscience has announced the acquisition of PreClinOmics, which will see the US-based drug discovery solutions company expand its cardiovascular …
News
merckincweb2

MSD joins charity-industry partnership Dementia Consortium

March 9, 2016 Medical Communications, Research and Development MSD, alzheimer's society, dementia, dementia consortium

The Dementia Consortium has welcomed MSD into the fold as a new partner in its global venture to accelerate drug …
News
medimmune_logo_on_building

AZ drug gets orphan status for rare inflammatory disease

March 9, 2016 Research and Development AstraZeneca, MEDI-551, MedImmune, orphan drug

AstraZeneca’s biologics R&D arm MedImmune has been granted Orphan Drug Designation by the FDA for its investigational anti-CD19 monoclonal antibody, …
News

Genmab ends ofatumumab trials for autoimmune conditions; to focus on multiple sclerosis

March 9, 2016 Research and Development Arzerra, GSK

Danish drug-company Genmab (Nasdaq Copenhagen: GEN) said it will discontinue the late-stage trials for Arzerra (ofatumumab) to develop a treatment for …
News

Medimmune gets US FDA fast track designation for flu drug

March 9, 2016 Research and Development

UK drug major AstraZeneca (LSE: ANZ) said its biologics R&D unit, MedImmune, has received Fast Track designation from the US …
News
bayercross3

Bayer to collaborate on new treatments for tuberculosis with Universities of Dundee, Cape Town

March 8, 2016 Manufacturing and Production, Research and Development Bayer, TB, tuberculosis, university of cape town, university of dundee

The pharmaceuticals division at German-based Bayer will collaborate with the renowned medicinal chemistry and biology departments at the Universities of …
News
sanofi_pasteur_msd

Sanofi Pasteur and MSD end European vaccines partnership

March 8, 2016 Medical Communications, Research and Development, Sales and Marketing MSD, Sanofi Pasteur, Sanofi pasteur msd, vaccines

Sanofi Pasteur and MSD have announced that they will end their joint vaccines operations in Europe, bringing an end to …
News
microsoft_novartis_kinect

Novartis and Microsoft team up for Kinect collab

March 8, 2016 Manufacturing and Production, Research and Development Microsoft, Novartis, multiple sclerosis

Novartis has partnered with technology giant Microsoft; hoping to use its Kinect motion sensor to quantify whether its multiple sclerosis …
Feature
sensimed_lens

Wireless contact lens sensor approved by FDA

March 8, 2016 Manufacturing and Production, Research and Development, Sales and Marketing

The US Food and Drug Administration has allowed the marketing of a contact lens sensor that may help practitioners identify …
News
abbvie

AbbVie pays $595m upfront for experimental Boehringer psoriasis drug

March 8, 2016 Manufacturing and Production, Research and Development, Sales and Marketing AbbVie, BI 655066, Boehringer Ingelheim, psoriasis

AbbVie is betting big on the future of an experimental psoriasis drug, paying $595m upfront for the rights to Boehringer …
News
rd_hands

Shares in Celldex halve in value as it discontinues trial of brain cancer drug

March 8, 2016 Manufacturing and Production, Research and Development Cancer, Celldex, research

Shares in Celldex Therapeutics (Nasdaq: CLDX) more than halved in value on the Nasdaq Monday as the company said independent regulators …
News
7-0_careers_taleobanner_900x600

Onconova says Baxalta ends $565 million drug development deal for rigosertib

March 8, 2016 Manufacturing and Production, Research and Development Baxalta, Onconova Therapeutics, drug development, rigosertib

Onconova Therapeutics says Baxalta has terminated its $565 million agreement to jointly develop the company’s lead drug candidate rigosertib. Baxalta …
News
The Gateway to Local Adoption Series

Latest content

Just – Evotec given Gates Foundation grant to increase global biotherapeutics access

January 8, 2026

Johnson & Johnson submits robotic surgical system for De Novo classification

January 8, 2026

EA Pharma announces phase 3 trial for new schizophrenia treatment in Japan

January 7, 2026

Eleva appoints Erich Rajkovic as Chief Business Officer

January 7, 2026

MedPharm announces US FDA inspection of North Carolina manufacturing facility

January 6, 2026